Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Allurion Technologies, Inc. is a medical device company focused on combating obesity through its innovative Allurion Program, which features the swallowable, Procedureless™ intragastric balloon for weight loss. Targeting the $54 billion global obesity treatment market, Allurion aims to serve over 10 million potential U.S. patients. The company enhances patient outcomes with AI-powered remote monitoring and behavior change tools, while expanding its offerings to include weight loss medications and combination therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.